专题报道 |
|
|
|
|
5-氟尿嘧啶—烟酰胺共晶的制备及其抗肿瘤活性研究 |
吴敏( ),刘馨刚,薛宇,陈琪,胡秀荣,周峻,汤谷平*( ) |
浙江大学化学系, 浙江 杭州 310027 |
|
Synthesis, characterization and antitumor activity of 5-fluorouracil-nicotinamide cocrystal |
WU Min( ),LIU Xingang,XUE Yu,CHEN Qi,HU Xiurong,ZHOU Jun,TANG Guping*( ) |
Department of Chemistry, Zhejiang University, Hangzhou 310027, China |
引用本文:
吴敏,刘馨刚,薛宇,陈琪,胡秀荣,周峻,汤谷平. 5-氟尿嘧啶—烟酰胺共晶的制备及其抗肿瘤活性研究[J]. 浙江大学学报(医学版), 2017, 46(2): 160-166.
WU Min,LIU Xingang,XUE Yu,CHEN Qi,HU Xiurong,ZHOU Jun,TANG Guping. Synthesis, characterization and antitumor activity of 5-fluorouracil-nicotinamide cocrystal. J Zhejiang Univ (Med Sci), 2017, 46(2): 160-166.
链接本文:
http://www.zjujournals.com/xueshu/med/CN/10.3785/j.issn.1008-9292.2017.04.07
或
http://www.zjujournals.com/xueshu/med/CN/Y2017/V46/I2/160
|
1 |
BLAGDEN N , DE MATAS M , GAVAN P T et al. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates[J]. Advanced Drug Delivery Reviews, 2007, 59 (7): 617- 630
doi: 10.1016/j.addr.2007.05.011
|
2 |
LONGLEY D B , HARKIN D P , JOHNSTON P G . 5-fluorouracil: mechanisms of action and clinical strategies[J]. Nat Rev Cancer, 2003, 3 (5): 330- 338
doi: 10.1038/nrc1074
|
3 |
JORDAN V C . A retrospective: on clinical studies with 5-Fluorouracil[J]. Cancer Research, 2016, 76 (4): 767- 768
doi: 10.1158/0008-5472.CAN-16-0150
|
4 |
GRAPSA D , SYRIGOS K , SAIF M W . Nanoliposomal irinotecan for treating pancreatic cancer[J]. Expert Opin Orphan Drugs, 2016, 4 (5): 541- 547
doi: 10.1517/21678707.2016.1169171
|
5 |
KRISHNAIAH Y S , SATYANARAYANA V , KUMAR B D et al. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil[J]. Eur J Pharm Sci, 2002, 16 (3): 185- 192
doi: 10.1016/S0928-0987(02)00081-7
|
6 |
MALET-MARTINO M , MARTINO R . Clinical studies of three oral prodrugs of 5-fluorouracil (capecitabine, UFT, S-1): a review[J]. Oncologist, 2002, 7 (4): 288- 323
doi: 10.1634/theoncologist.7-4-288
|
7 |
LI S , CHEN J M , LU T B . Synthon polymorphs of 1:1 co-crystal of 5-fluorouracil and 4-hydroxybenzoic acid: their relative stability and solvent polarity dependence of grinding outcomes[J]. Crystengcomm, 2014, 16 (28): 6450- 6458
doi: 10.1039/C4CE00221K
|
8 |
DELORI A , EDDLESTON M D , JONES W . Cocrystals of 5-fluorouracil[J]. Crystengcomm, 2013, 15 (1): 73- 77
doi: 10.1039/C2CE26147B
|
9 |
HATTORI Y , SATO M , OTSUKA M . Initial dissolution kinetics of cocrystal of carbamazepine with nicotinamide[J]. J Pharm Pharmacol, 2015, 67 (11): 1512- 1518
doi: 10.1111/jphp.12461
|
10 |
ZHANG S W , KENDRICK J , LEUSEN F J et al. Co-crystallization with nicotinamide in two conformations lowers energy but expands volume[J]. J Pharm Sci, 2014, 103 (9): 2896- 2903
doi: 10.1002/jps.23929
|
11 |
LEHN J M . Supramolecular chemistry scope and perspectives-molecules supermolecules Molecular Devices[J]. Chemica Scripta, 1988, 28 (3): 237- 262
|
12 |
SERRANO D R , O'CONNELL P , PALUCH K J et al. Cocrystal habit engineering to improve drug dissolution and alter derived powder properties[J]. J Pharm Pharmacol, 2016, 68 (5): 665- 677
doi: 10.1111/jphp.2016.68.issue-5
|
13 |
LIU L D , LIU S L , LIU Z X et al. Synthesis, structure, antitumor activity of novel pharmaceutical co-crystals based on bispyridyl-substituted alpha, beta-unsaturated ketones with gallic acid[J]. J Molecular Structure, 2016, 1112 1- 8
doi: 10.1016/j.molstruc.2016.02.025
|
14 |
STEINER T . The hydrogen bond in the solid state[J]. Angew Chem Int Ed Engl, 2002, 41 (1): 49- 76
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|